Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

payer survey

- PMLiVE

Jonathan Fox leaves AstraZeneca for MyoKardia

Will lead programme to target genetic heart disease

- PMLiVE

NICE turns down diabetes and ovarian cancer drugs for NHS use

Disappointment for BMS/AZ’s Forxiga and Roche’s Avastin

EU flag

European CRO market set to reach $11.54bn by 2018

Frost and Sullivan expects outsourcing efforts to increase

- PMLiVE

AZ swipes Fishburn Hedge’s healthcare lead

Ayesha Bharmal joins the pharma company as global media relations director

- PMLiVE

Is the single-minded proposition fit for 2013?

Thought Leader: A single-minded proposition may be reductionist, but a good one will contain a necessary tension that can be explored

- PMLiVE

inVentiv renames its CRO as inVentiv Health Clinical

Aligning company’s clinical segment with its commercial services

Bedrock hires new client services director

Patricia Forsyth joins from Acumed

- PMLiVE

Bayer’s Diane 35 faces ban in France

Follows investigation into blood clot-related deaths

- PMLiVE

FDA advisors back Boehringer’s COPD drug olodaterol

Committee votes 15 to 1 in favour despite cancer concerns

Roche - Basel

Roche delivers solid sales gain in 2012

New cancer products, such as Perjeta and Zelboraf, help growth

- PMLiVE

Anker Lundemose appointed CEO of Bionor Pharma

Will lead efforts to develop and commercialise HIV vaccines

- PMLiVE

Healthcare UK launches to sell NHS expertise abroad

Will provide services to international private and public healthcare providers

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links